Vigilare Wealth Management Supernus Pharmaceuticals, Inc. Transaction History

Vigilare Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$25.33 - $34.25 $177,208 - $239,613	-6,996 Closed	0 $0
Q1 2022 Apr 06, 2022	SELL	$28.51 - $32.9 $136,848 - $157,920	-4,800 Reduced 40.69%	6,996 $226,000
Q4 2021 Jan 07, 2022	SELL	$26.37 - $34.22 $37,577 - $48,763	-1,425 Reduced 10.78%	11,796 $344,000
Q3 2021 Oct 19, 2021	BUY	$23.54 - $31.39 $97,691 - $130,268	4,150 Added 45.75%	13,221 $353,000
Q2 2021 Jul 16, 2021	BUY	$26.72 - $33.19 $32,064 - $39,828	1,200 Added 15.25%	9,071 $279,000
Q1 2021 Apr 29, 2021	BUY	$24.15 - $31.45 $190,084 - $247,542	7,871 New	7,871 $206,000

301

60.7M

8.8K

6.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.79B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.